Although the mammalian microbiota is well contained within the intestine, it profoundly shapes development and metabolism of almost every host organ. We questioned the range and depth of microbial metabolite penetration into the host, and how this is modulated by intestinal immunity. Chemically identical microbial and host metabolites were distinguished by stable isotope tracing from 13 C-labeled live non-replicating Escherichia coli, differentiating 12 C host isotopes with high-resolution mass spectrometry. Hundreds of endogenous microbial compounds penetrated 23 host tissues and fluids after intestinal exposure: subsequent 12 C host metabolome signatures included lipidemia, reduced glycolysis, and inflammation. Penetrant bacterial metabolites from the small intestine were rapidly cleared into the urine, whereas induced antibodies curtailed microbial metabolite exposure by accelerating intestinal bacterial transit into the colon where metabolite transport mechanisms are limiting. Pervasive penetration of microbial molecules can cause extensive host tissue responses: these are limited by immune and non-immune intestinal mucosal adaptations to the microbiota.
Correspondence sauer@imsb.biol.ethz.ch (U.S.), andrew.macpherson@insel.ch (A.J.M.) In Brief Bacteria-derived metabolites pervade the mammalian host, shaping immunity and metabolism. Using stable isotope tracing, Uchimura and colleagues profile the scope and depth of host tissue penetration by bacterial metabolites. Extensive host immune and metabolic responses to microbial metabolite penetration are constrained by secretory antibodies that limit microbial smallintestinal dwell time.
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INTRODUCTION
The relationship between mammals and their resident microbiota shapes both the microbial communities and every host organ system from conception until death. There are extensive differences in all body systems between animals of the same strain in a germ-free or colonized state (Smith et al., 2007) ; most effects of the microbiota are seen if a germ-free animal is colonized at any age, including but not limited to intestinal secretory immunoglobulin (Ig)A induction (Gensollen et al., 2016) . Given these ubiquitous interactions over all body systems, it is unsurprising that almost every disease model has been reported to be sensitive to microbial colonization status (Belkaid and Harrison, 2017; Blumberg and Powrie, 2012; Sommer and B€ ackhed, 2013) . Since the biomass of the microbiota is well separated from host tissues except during pathogenic infections, at first sight it is paradoxical that the presence of the microbiota shapes the cellular composition and function of non-intestinal mammalian organs so extensively, even when they are almost always sterile. The answer probably lies mainly in the penetration of microbial metabolites, which in some cases have been shown to exert powerful effects on host cell differentiation and metabolism. Microbial metabolite penetration of host tissues was first shown by detecting aromatic compounds in colonized but not germ-free animals more than 40 years ago (Cotran et al., 1960; Dayman and Jepson, 1969) . Typically, metabolites are inferred to originate from microbial metabolism when they are present in host tissues only when animals are fully colonized or harbor specific compositions of microbial consortia (El Aidy et al., 2013; Nicholls et al., 2003; Williams et al., 2002) . This approach is ambiguous for those compounds that can be synthesized either by host or microbial metabolism, because an increased metabolite concentration after microbial colonization may be due to the propagation from microbes or to the host metabolic response to their presence.
Stable isotope tracing to differentiate microbial or host origins of chemically identical metabolites has so far been used to follow gut microbial metabolism in an in vitro model where host effects are eliminated (de Graaf et al., 2010) or to show selective utilization of carbon sources resistant to host digestion by in vivo incorporation into microbial RNA of a limited number of species within the intestinal consortia (Tannock et al., 2014) . These labeled nutrient supplementation approaches are thus limited to spotlighting the fate of individual nutrients within the microbial communities themselves.
Assessing overall penetration of host tissues with microbial metabolites requires selective labeling of all microbial (but not host) molecules, yet avoiding exponential dilution of the label as bacteria use host or nutritional carbon sources to divide in vivo. We developed a strategy where germ-free mice are gavaged with a dose of either 12 C-or fully 13 C-labeled live E. coli HA107 that cannot replicate in the germ-free intestine (Hapfelmeier et al., 2010) , so the 13 C-label is not immediately and exponentially diluted in vivo through bacterial replication using host-or food-derived 12 C nutrients. High-resolution mass spectrometry Sé vin et al., 2017) was then used to reveal both the 13 C host penetration by microbial metabolites and the 12 C host metabolome response to the presence of the microbes in fasting animals. Although E. coli is a minor constituent of the adult human microbiota, it is a prominent member of the early life microbiota at a time when diversity is limited (B€ ackhed et al., 2015) , and thus models some aspects of early-life host-microbial molecular interactions from a low-diversity microbiota.
A second problem in resolving the in vivo mechanisms that determine the molecular exchange between intestinal microbes and their mammalian host is that the intestinal mucosa itself is extensively reprogrammed by exposure to intestinal microbes through epithelial cell differentiation, secretion of antibodies, antibacterial polypeptides, microvascular development, and xenobiotic metabolic pathway induction (Gomez de Ag€ uero et al., 2016; Hooper et al., 2001; Macpherson et al., 2000; Stappenbeck et al., 2002; Vaishnava et al., 2011) . This means that microbes instruct the very mechanisms that build the dynamic interface separating the host, its intestinal microbes, and their metabolites. 13 C-labeled bacterial challenge of a colonized animal would largely obscure distinction of microbial and host compounds based on the observed isotopes, because of the much larger load of natural 12 C metabolites from the resident microbiota. We have resolved this problem using a system that allows maturation of the intestinal barrier in germ-free animals through transient intestinal live microbial preconditioning without permanent colonization (Hapfelmeier et al., 2010) . This approach allowed us to compare microbial-host metabolite exchange directly in fasting germ-free mice, with or without prior microbial-driven mucosal adaptations including Ig induction. The combination of this isotope tracing approach and the transient colonization model has provided a unique insight into how microbial transit through the small intestine and propagation of microbial metabolites throughout the host are checked by secretory and metabolic adaptations of the intestinal mucosa.
RESULTS
A Broad Scope of Intestinal Bacterial-Derived Metabolites Penetrates Host Systemic Organs
While a few microbial metabolites, such as short chain fatty acids or aryl hydrocarbon receptor ligands, are well known to shape host metabolism and immune functions (Arpaia et al., 2013; Gomez de Ag€ uero et al., 2016; Perry et al., 2016; Smith et al., 2013b) , we do not know the full extent of microbial metabolite penetration, nor the entire scope of consequent host metabolic responses. To assess the propagation of host-microbial mutualism in 16 mouse tissues and 7 fluids systematically, we gavaged fully 13 C-labeled or 12 C live E. coli HA107, which cannot replicate in vivo, into fasting C57BL/6 germ-free mice ( Figure S1A ). By employing high-resolution untargeted massspectrometry with high throughput methodology (Fuhrer et al., 2011 Sé vin et al., 2017) , we resolved more than 1,000 annotated compounds (M r 50-1,000 Da at 1 mD resolution) and determined the mass shift showing 13 C or 12 C proportions within each molecule (Figures S1B and S1C) . Molecules from fully 13 Clabeled bacteria (Figures S1D and S1E) showed bacterial metabolite exposure (Figures S1B and S1F) . However, if the molecule concerned came from the 12 C host response rather than the bacteria (whether or not the challenge bacteria were 13 C-labeled), it gave an appropriate mass/charge ratio signal, but without the 13 C mass shift (Figure S1C , illustrated for a hypothetical C 4 compound). These experiments can distinguish host and pre-existing endogenous microbial compounds in fasting mice, rather than products of bacterial metabolism from dietary carbon sources.
Two hours after gavage, a wide range of 13 C-labeled bacterial metabolites had already propagated into the host to reach almost all fluids and organs (Figures 1, 2A-2C, and S2A-S2C). However, the distribution of different compound classes varied. Bacterial amino acids (including essential amino acids) penetrated very widely over all host tissues (Figures 1 and S2A ). Other bacterial metabolites, including five-and six-membered ring and heterocyclic compounds, were present in the serum and rapidly excreted in the urine ( Figures 2B and S2C ). Urinary lipid amounts were generally low, consistent with known lipoprotein exclusion from glomerular filtration (Figures 2B and S2B) . Bacterial fatty acids and glycerolipids were present mainly in the small intestinal tissue and mesenteric lymph nodes (Figure 2C) , consistent with lymphatic uptake. Most compound classes apart from lipids were able to penetrate into the peritoneal fluid of these naive germ-free mice (compare analysis of different compound classes from Figure 2A shown in Figures S2A, S2C , with S2B). By 18 hr, the front of detected 13 C-labeled metabolites had moved along the intestine to reach the cecum and the colon (compare Figure 2A insets and S2A-S2F insets at 2 and 18 hr), consistent with the known murine intestinal transit times (Padmanabhan et al., 2013) . Although bacterial metabolites had been cleared from the small intestinal fluid and peritoneum by 18 hr (Figure S2D -S2F), they were still present in small intestinal tissues ( Figure 2C ) and being excreted at low amounts in the urine and the bile ( Figure 2B ). In many cases the bacterial metabolites detected in these unconditioned germ-free mice constituted a high proportion of the total (bacterial+host) concentration for that metabolite across different fluids and tissues of the mouse ( Figure S2G ).
Since the HA107 system depends on cell wall auxotrophy to abrogate in vivo replication, we asked whether increased bacterial fragility of the HA107 system generates increased systemic exposure of bacterial metabolites by comparing penetration of compounds from HA107 or its non-auxotrophic parent strain. For maximum sensitivity, challenge bacteria were labeled by growth in 14 C glucose. Although 14 C metabolic labeling reveals only the bacterial origin of the radiolabel but not the original molecular identity of the bacterial compound, it had the advantage that we could measure overall 14 C transfer, whereas bacterial replication in vivo would dilute the proportion of 13 C-label and potential underestimation of penetration. We found overlapping ranges of radiolabel recovery in serum, urine, and host tissues and no significant differences at most time points, regardless of whether or not the test bacteria were engineered with cell wall auxotrophy ( Figures 3A, 3B , and S3A-S3C). We also confirmed that our method of bacterial gavage into the stomach in buffer did not result in gastric microbial death. A single bacterium of the replication competent parent strain of E. coli HA107 was sufficient to permanently colonize the intestine ( Figure S3D ). Second, direct measurement recovery of a dose of 1 3 10 7 CFU HA107 from the luminal contents and mucosal scrapings of the intestine showed that 85.6% ± 4.4% (x ± SD, n = 6) of the gavage dose was present in the small intestine 90 min after administration and 73.3% ± 5.1% from the small intestine and the cecum 150 min after administration. Third, radiolabel penetration from 14 C HA107 or its non-auxotrophic parent strain was equivalent but substantially less than the same dose of 14 C HA107 material that had been lysed by sonication (Figure S3E) . Hence there was no evidence for immediate gastric lysis, nor that potential fragility of the employed HA107 strain would liberate more endogenous metabolites than wild-type E. coli. Gavage with 13 C-E. coli We concluded that there is extensive penetration of an extremely broad range of bacterial-derived molecules into host tissues from the germ-free intestine, even though live bacteria penetrate only as far as the local (mesenteric) lymph nodes (Hapfelmeier et al., 2010) . These results did not distinguish the relative penetration through the small or large intestinal surfaces, nor show how prior mucosal adaptation of the germ-free intestine through secretory Ig induction, antibacterial peptides, and a consolidated barrier function (Hapfelmeier et al., 2010; Petersson et al., 2011; Salzman et al., 2010; Vaishnava et al., 2011) could shape microbial-host molecular exchange at both small and large intestinal surfaces.
The Small Intestine Is the Predominant Interface for Metabolite Penetration of Intestinal Microbes
The small intestine has minimal mucus coverage and is highly adapted for molecular uptake, whereas the large intestine has a thick layer of protective mucus overlying the epithelium (Johansson et al., 2008) . We compared uptake of 14 C HA107 after delivery into the stomach or after direct in vivo mixing with cecal contents. 14 C labeling was also used in this experiment to detect host exposure to microbial metabolites with maximum sensitivity, even if they underwent secondary metabolism in the host. There was substantial radiolabel uptake from the upper intestine and recovery in the urine, but little uptake from cecal bacteria (Figures 3A, 3B, . This verified that the small intestine was the main absorptive surface for extensive microbial molecular exchange with host organ systems, and supported results with the specific molecular 13 C system that the urine is a highly effective immediate elimination route.
The lower small intestine is normally colonized with intestinal microbes, so microbial molecular exposure has potentially important biomedical consequences. Mice are naturally coprophagic, but even adult humans or infants with reduced intestinal motility can have high densities of microbes in the proximal small intestine (Donowitz et al., 2016; Jones et al., 2011) . In the developing world, small intestinal microbes cause childhood environmental enteropathy with malnutrition and growth stunting, affecting up to 25% of children aged under 5 years (Korpe and Petri, 2012) .
Maturation of the Intestinal Mucosal Barrier after Transient Live Microbial Exposure Is Durable and Involves Immune and Non-immune Transcriptional Reprogramming
Secretory IgA is known to be induced by small intestinal microbes (Bunker et al., 2015) , and environmental enteropathy is associated with compensatory secretory IgA responses against microbes responsible for the loss of intestinal function (Beatty et al., 1983; Kau et al., 2015) . We therefore addressed whether antibodies or other barrier functions that are induced as a result of exposure to intestinal microbes constrain microbial metabolite penetration and how this impacts the body metabolome of the host response.
To assess how mucosal protective factors affect bacterial metabolite exchange in the intestine, we needed to experimentally uncouple maturation of the mucosa and its barrier functions from permanent colonization. To confirm the extent of mucosal Figure S2 .
adaptations after live reversible E. coli HA107 colonization, we carried out transcriptomic analysis of the intestinal mucosa 2 weeks later, once mice had returned to germ-free status ( Figure 3C ). In line with our earlier results demonstrating a persistent IgA response (Hapfelmeier et al., 2010) , we found a series of significantly upregulated Ig transcripts 2 weeks after transitory exposure to HA107. In addition, there was upregulation of genes with known functions in xenobiotic and metal metabolism, mitochondrial function, ion channels, angiogenesis, and epithelial microbiocidal peptide expression ( Figures 3C and  3D) . In a complementary approach, in vivo endomicroscopy was used to compare the endothelial to epithelial ratios in the small intestine of transiently colonized and sham control animals (Figure 3E) , consistent with earlier observations of an increased microvascular density induced by permanent colonization with Bacteroides thetaiotaomicron (Stappenbeck et al., 2002) .
We concluded that even transitory mucosal conditioning by intestinal bacteria results in extensive re-programming of immune, epithelial, and stromal elements of the intestinal mucosa of adult animals that is durable after the mice have returned to germ-free status. Thus, in principle we could evaluate the barriers to microbial molecular penetration through the intestine by comparing secondary bacterial challenge in germ-free mice that had previously been preconditioned by transient colonization with unconditioned germ-free controls.
Immunoglobulin Induction Accelerates Small Intestinal Transit of Bacteria and Their Metabolites
To determine how mucosal adaptation or antibody induction, or both, affect the depth of metabolite penetration, we compared germ-free C57BL/6 wild-type with Igh-J-deficient mice lacking all antibody isotypes due to deletion of the J-segments of the Ig heavy chain locus (Chen et al., 1993) . This avoided the confounding effects of compensatory intestinal IgM and overinduction of systemic IgG in animals selectively deficient for the IgA isotype (Harriman et al., 1999) . Groups (R18) of germ-free wild-type C57BL/6 and Igh-J À/À mice were preconditioned with HA107; separate groups of each strain were treated in parallel with sterile PBS as controls. Preliminary experiments established that 14 C HA107-treated mice had no residual detectable radiolabel 14 days after treatment. Two weeks after the preconditioned HA107-treated mice had returned to germ-free status, they were divided into 3 groups of R6 animals of each strain to be challenged with a single dose of 13 C-or 12 C-HA107, or sterile PBS, administered directly into the stomach ( Figure S1Aii ). To investigate how antibodies modulated the effect of preconditioning, we compared the relative difference of positive fold-changes due to propagation of 13 C-labeled compounds between pre-and unconditioned germ-free mice from the C57BL/6 and Igh-J À/À strains (Figures S1B, S1C, 4A, and 4B). Two hours after bacterial challenge, conditioned C57BL/6 mice showed increased bacterial metabolites in the cecal fluid and colonic fluid compared with the antibody-deficient Igh-J À/À strain (p < 0.001 for all measured compounds and for different compound classes considered individually in colonic fluid; Figures 4A and 4B) . In contrast, bacterial compounds were enriched in the small intestinal fluid of unconditioned mice compared to conditioned mice ( Figure 4A ). Since these results were generalized across compound classes, we hypothesized that induced secretory Ig accelerated the transit of intact intestinal bacteria, either through limiting bacterial motility, reducing adherence, or exclusion effects.
We verified in our reversible colonization system that maximum concentrations of secretory IgA directed against intestinal bacteria were expressed in the small intestine (Figure S4A; Bunker et al., 2015) and that these IgA antibodies coated the HA107 challenge organisms and their flagella (Figures S4B-S4D) .
The hypothesis that induced immunoglobulins directly accelerate the small intestinal transit of intestinal bacteria was confirmed by showing faster small intestinal transit ( Figure 4C ) and fecal shedding ( Figure 4D ) of a test dose of HA107 from preconditioned germ-free C57BL/6 mice compared with preconditioned germ-free Igh-J À/À controls. By 18 hr, most of the load of challenge bacteria had been cleared from the colon of the C57BL/6 wild-type mice. Similar results were obtained comparing pretreated and non-treated control C57BL/6 mice (not shown). Given that isolated loop experiments had showed no difference in the survival of the bacteria in the intestine whether or not the animals could express antibodies ( Figure S4E ), we considered whether IgA coating of flagella ( Figure S4B , enlarged area) could explain rapid clearance of bacteria from the small intestine. Small intestinal secretions contained anti-flagellin antibodies of the IgA isotype ( Figure S4F ) and intestinal fluid from preconditioned C57BL/6 but not Igh-J-deficient mice attenuated the motility of the bacterial strain (Figure S4G and Videos S1 and S2). Precoating with intestinal fluid from preconditioned C57BL/ 6 mice, but not Igh-J-deficient mice, also limited the bacterial motility in a motility agar assay (Figure S4H Germ-free C57BL/6 mice (red) or antibody-deficient Igh-J À/À mice (blue) were preconditioned with HA107 or control treated. Twelve days after all groups had returned to germ-free status, they were gavaged with 13 C-labeled HA107 or PBS as control (n = 3-4 per group) and Log 2 fold-changes were calculated (Figure S1Aii antibody-dependent clearance from the small intestine, increased bacterial motility in the absence of secreted small intestinal antibodies potentially allows bacteria to move against the flow of small intestinal secretions, and hence increases exposure of the host to their small intestinal metabolites.
Non-immune Mechanisms of Prior Intestinal Conditioning with Live Microbes Determine the Bodily Distribution and Excretion of Microbial Metabolites
So far, we had found that without conditioning 13 C bacterial metabolites appear in the peritoneal fluid of C57BL/6 and antibodydeficient mice early after the bacterial challenge ( Figures 2A, 2B , S2A-S2C, 5A, and S5A). However, instead of accumulation in the peritoneum, there was preferential elimination in the urine after preconditioning: this effect was antibody independent as it was seen in both wild-type and antibody-deficient animals (Figure 5A) . At later times there was persistent uptake of bacterial molecules from the intestine into the serum of conditioned antibody-deficient mice ( Figure 5B), reflecting the increased dwell time of bacteria in the small intestine ( Figures 4C and 4D ). Since metabolites were very effectively filtered into and concentrated within the urine, and the lower serum concentrations remain constant until at least 18 hr (compare Figures 3A and 3B ), we concluded that the general preconditioning response improved early clearance of metabolites into the urine. Increased cardiac output and peripheral perfusion have been observed by comparing germ-free and colonized mice (Smith et al., 2007) , and bacterial pre-conditioning also increases intestinal microvascular density ( Figure 3E ) which likely favors early metabolite uptake through the intestinal microvasculature and rapid clearance into the urine as an antibody-independent effect ( Figure 5A ). From the results showing increased dwell time of bacteria in the small intestine of antibody-deficient mice, we expected to detect increased bacterial metabolites in intestinal tissues. This was found in the small intestine, mesenteric lymph nodes, and some systemic tissues ( Figures 5C and 5D ). Specifically, we found that these bacterial metabolites in the ileum of conditioned antibody-deficient mice included potentially inflammatory biogenic amine indole derivates such as methoxytryptamine, methoxytryptophol, methoxydimethyltryptamine, and serotonin ( Figure 5E ). In some cases, there was evidence of 12 C incorporation into the dominantly 13 C-labeled metabolites (Table S1 specifies molecular mass-shift results from Figure 5E ), indicating formation after additional host or bacterial metabolism in vivo.
There was also evidence of bacterial saccharides such as arabitol and galactose-xylose normally associated with bacterial but not host metabolism ( Figure 5E ). The serum of conditioned antibody-deficient mice contained increased bacterial non-esterified fatty acids, most of which were fully 13 C-labeled ( Figure 5F and Table S1 ). Increased lipid exposure as a function of colonization was verified in permanently colonized chow-fed animals ( Figure S5B ). It is therefore likely that the bacterial lipid load makes a substantial contribution to host lipids, particularly in the context of defective intestinal barrier function.
Natural Antibodies Binding to Microbial Metabolites Are Induced by Transient Colonization of Germ-free Mice
Given that we had shown binding of induced IgA against the HA107 transient colonizer, we also addressed whether binding to any of its bacterial metabolites could be detected. Using pure compounds selected from the results of the 13 C mass spectrometric identifications, we carried out ELISA binding studies comparing intestinal IgA from C57BL/6 mice and antibody-deficient controls, with and without prior transient colonization. This showed antibody binding against identified authentic metabolites (Figures 5E and 5F), including heptadecanoic acid, pentadecanoic acid, scopolamine, and N-acetylaspartylglutamic acid, with E. coli DNA as positive control and maltose as negative control ( Figure S5C ). These are likely amplified natural specificities (Bunker et al., 2017) as the binding curves of germ-free and transiently colonized mice superimposed when corrected for IgA concentration (Figure S5C insets) . Nevertheless, natural IgA per se was insufficient to block the responsiveness of the mucosa independently of small intestinal bacterial clearance. Cytokine secretion induced in ileal explants by the presence of bacteria was affected neither by specific IgA added to the explant system, nor when the explants themselves were from animals expressing mucosal IgA ( Figure S5D ). We concluded that the principal effect of antibody induction on metabolite exposure is to reduce the bacterial dwell time of the source microbe, rather than preventing adherence or access of the released metabolites to the intestinal mucosa.
Persisting Exposure of Antibody-Deficient Mice to Bacterial Metabolites Results in Increased Host Cytokine and Metabolomic Responses
Given the pervasive penetration of bacterial-derived metabolites in many different host tissues in antibody-deficient animals, including inflammatory triggers such as biogenic amines and lipids ( Figures 5B and 5C ), a metabolic and immune host response was expected. To address this in molecular terms, Table S1 . Metabolites with Tanimoto chemical similarity R 0.7 are interconnected and node size shows fold-increase. The paired Mann-Whitney U test was applied to calculate the p value of each network.
(F) As (E), except analysis of blood metabolite networks. Results are representative of three experiments. See also Figure S5 .
(legend on next page)
we exploited the discrimination power of the stable isotope tracing system by analyzing the changes in 12 C metabolite amounts across different host tissues that were independent of whether a 13 C or 12 C bacterial challenge dose had been given ( Figure S1C) . Tissue 12 C-metabolite measurements 18 hr after a transient dose of either 13 C-labeled or 12 C HA107 showed both increases and loss of different specific metabolites in intestinal and systemic tissues of conditioned antibody-deficient compared with wild-type mice ( Figures 6A-6C ).
The hypothesis that antibody-dependent clearance of bacteria from the small intestine as a mechanism of limiting microbial metabolite exposure predicted that resulting immune responses would also be attenuated in vivo. Leukocyte cytokine release from different immune compartments in preconditioned wildtype and antibody-deficient mice showed that bacterial rechallenge generated inflammatory and non-inflammatory cytokine release and that this effect was generally less in conditioned C57BL/6 wild-type than in antibody-deficient mice ( Figure 6D ). Direct stimulation of leukocyte preparations with pure compounds that had been identified earlier as being of bacterial origin ( Figures 5E and 5F ) reproduced similar cytokine responses (Table S2) . These results verify clear immunostimulatory effects from the penetration of the identified bacterial metabolites and that the functional consequences of exposure are limited by antibody secretion.
As many of the compounds shown by their mass spectrometric signatures to be of host response origin in the in vivo experiments are not annotated in metabolic pathways, we used chemical similarity clustering analysis. For example, in antibody-deficient ileal tissues, the Tanimoto network of R2-fold changes comparing HA107-challenged Igh-J À/À antibody-deficient mice with unchallenged Igh-J À/À controls showed increased host lysophospholipids, phosphatidic acids, and non-esterified fatty acids with free head-groups such as arachidonic acid ( Figure 7A , Table S3 ). Increased arachidonic acid-derived host prostaglandins and leukotrienes including leukotriene E3 and prostaglandins A4, E2, F1a, and F2a were consistent with innate immune activation ( Figures S6A and 7A ). Increased prostaglandins and leukotrienes were also seen in the pancreas of conditioned antibody-deficient mice at 18 hr, following likely phospholipid breakdown ( Figures 6C, S6A , and 7B). In the blood of antibody-deficient mice, there were also increased host non-esterified fatty acids, as well as glycinated fatty acids (Figure 7C ), normally associated with lipid overload and deficient mitochondrial metabolism (Vianey-Liaud et al., 1987) . Therefore the lipidemia as a result of bacterial exposure in fasting mice is (1) of both bacterial and host origin and (2) can be triggered by antibody-unprotected exposure of the host to bacterial metabolites in the small intestine.
In contrast, the muscle and the spleen of antibody-deficient animals showed a loss of esterified and non-esterified lipids and increased saccharide intermediates ( Figures S6B, S7A , and S7B, Table S3 ). Fat tissue also showed accumulation of saccharide intermediates under these conditions ( Figure S7C ). These results are consistent with the established effects of lipotoxicity on lipid and carbohydrate metabolism triggered by circulating non-esterified fatty acids and eicosanoid signaling (Ertunc and Hotamisligil, 2016) .
To verify the protective importance of the antibody effect on small intestinal dwell time, we bypassed the effects of microbial conditioning of the intestinal mucosa and antibody control of bacterial transit by direct intraperitoneal injection of identified pure bacterial metabolites. This showed that there were clear responses in different lymphoid compartments, but these no longer consistently differed according to whether or not the mice secrete antibodies, or whether the intestinal mucosa had been preconditioned ( Figure S6C and Table S2 ).
DISCUSSION
The intestinal microbiota is commonly characterized in terms of its composition of different taxa: host responses or a disease phenotype are then correlated with specific taxa or a restricted range of microbial metabolites. Here we have presented a systematic analysis of the potential extent and reach of microbial-host molecular cross-talk from pre-formed endogenous microbial molecules and show that the microbiota itself induces immune and non-immune boundaries for microbialhost metabolite penetration. A few microbial taxa, such as segmented filamentous bacteria, deliver direct signaling through intimate apposition or attachment to the epithelial suface. Yet most of the microbial biomass exists in a highly dynamic system with constant microbial division and death, in the context of continuous transverse and longitudinal flow along the gastrointestinal tract.
Substantial rates of bacterial cell death have been described under steady-state colonization conditions (Maurice et al., 2013) . We did not find evidence that the cell wall auxotrophy of HA107 increased the fragility of the organism compared with its non-auxotrophic parent strain, and we could recover viable bacteria from fecal samples. Although challenge HA107 bacteria Germ-free C57BL/6 mice (black symbols) or antibody-deficient Igh-J À/À mice (green) were preconditioned with HA107 or control treated, returning to germ-free status 12 days prior to re-challenge with a gastric dose of fully 13 C-labeled or 12 C HA107. Tissue samples were collected after 18 hr for Q-TOF mass spectrometry.
Annotated ions representing metabolites containing concordant changes from 13 C and 12 C pulsed mice without mass shift were plotted.
(A and B) Log 2 fold-change differences between preconditioned and control mice for each metabolite is shown for (A) duodenal, jejunal, and ileal tissues; (B) mesenteric lymph nodes, blood, muscle, and adipose tissues. [85]
Leukotriene E3 [47] PIP ( Host metabolite response increased in conditioned Igh-J /-blood 18 hours Oxo-dihydro-20-COOH-LTB4 [18] Retinal Numbers in squared brackets refer to the metabolite annotation (TableS3).
in these experiments were efficiently recovered from the feces, bacterial death in the mouse intestine certainly contributes to the metabolite load. This is not restricted to the HA107 model: in vivo replication rates and overall dynamics indicate high rates of bacterial death in the intestine (Li et al., 2015; Myhrvold et al., 2015) . Partitioning of bacterial molecules from effete cells into the host has parallels with symbiosis in the rhizosphere. Nevertheless, given the inflammatory potential of bacterial molecules, the vulnerability of the host is reduced by antibodies that likely limit its exposure to metabolites from dead bacteria. Exposure to intestinal microbes drives durable adaptation of the intestinal mucosa through immune and non-immune mechanisms. Beneficial effects of intestinal Ig secretion include toxin and virus neutralization, blocking excessive live bacterial translocation, clearance of unwanted macromolecular structures at the epithelial surface, and directed sampling of luminal antigen (Macpherson et al., 2018) . Lack of specific IgA has been shown to increase transcriptional evidence of innate immune system activation in the intestine (Peterson et al., 2007) . We now show that antibody induction and secretion decreases microbial motility, accelerates in vivo intestinal transit, and limits exposure of the small intestinal mucosa to the pro-inflammatory molecular constituents of intestinal microbes. Only extremely low titers of specific serum IgG occur after intestinal preconditioning (Gomez de Ag€ uero et al., 2016); we therefore tested the elimination of all antibody isotypes to avoid the compensatory effects of IgM secretion and increased IgG induction in IgA deficiency (Harriman et al., 1999) or the enteropathy that occurs with polymeric immunoglobulin receptor deficiency (Johansen et al., 1999) . It is likely that affinity matured secretory IgM can compensate IgA, and a role for IgG isotypes is not excluded.
These effects are poised on the small intestinal mucosa, where limiting bacterial metabolite uptake must be set against the necessity for nutrient absorption. In humans in the developed world, the lower small intestine has a microbial biomass of up to 10 7 organisms/mL intestinal contents. Globally, microbial colonization of the small intestine remains a severe problem. One of the most urgent biomedical problems of our age is to understand why the presence of high densities of small intestinal microbes in children from the undeveloped world causes intestinal dysfunction and infant malnutrition that cannot be adequately treated with caloric increases (Kau et al., 2015; Smith et al., 2013a) . Compensatory IgA that limits microbial metabolite exposure by decreasing the small intestinal dwell time may contribute to the protective effect for taxa that do not attach to or invade the epithelium. Reduction in an intestinal clearance effect is also consistent with the small intestinal lymphonodular hyperplasia in the setting of IgA and affinity matured IgM deficiency, owing to a deletion of activation-induced cytidine deaminase (Fagarasan et al., 2002) . We have distinguished bacterial metabolite exposure and resultant host responses with extremely wide coverage, even where the same molecule can be derived from either bacterial or host metabolism. The results attest to pervasive microbial metabolite exposure, over many classes of metabolites, including increased bacterial lipid penetration. A high proportion of the penetrant microbial metabolites were very rapidly excreted in the urine, although there were also durable increases, some of which benefit the host, such as essential amino acids. To be able to interrogate bacterial metabolite penetration at the same time as the host molecular response using stable isotope tracing, the model was limited to a single taxon; metabolite exposure from other taxa may vary according to their frequencies, flagellate statuses, and metabolic pathway differences.
While the breadth of metabolic exchange allows a broad portfolio of metabolic responses, the predominant effect in antibodydeficient fasting mice was lipidemia of both microbial and host origin, and host lipid breakdown in the intestine and the muscle. Breakdown of phospholipid components in the intestine was also accompanied by prostaglandin and leukotriene synthesis. Extending our model could potentially separate host or dietary molecular effects from microbial molecular effects in the fed as well as the fasting state.
A substantial investment of metabolic energy is made in the secretory IgA response which comprises approximately 75% of all immunoglobulin production in mammals (Macpherson et al., 2008) , most of which is secreted in the small intestine. The small intestine is a delicately positioned interface with the environment. On one hand, it is specialized for uptake of nutrients with minimal mucus covering and a combination of digestive and secretory mechanisms. Some of these nutrients are products of microbial metabolism, including vitamins, short chain fatty acids, and compounds capable of receptor signaling mechanisms that mature host organ systems (Gomez de Ag€ uero et al., 2016) . On the other hand, the small intestine must handle the inevitable contamination with intestinal microbes that expose the host to a range of compounds that potentially result in innate immune activation: this it does with a combination of physiological adaptations to clear microbial compounds quickly into the urine and secretory immunoglobulins accelerating transit away from the susceptible small intestinal mucosa, thereby modulating both microbial penetration into the host and the resultant host immune and metabolic responses.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Germ-free C57BL/6(J) and Igh-J À/À (Chen et al., 1993) mice were born and maintained in flexible-film isolators in the Clean Mouse Facility, University of Bern, Switzerland. Age and gender-matched mice were used at 10-12 weeks for the metabolomics samplings in this study. All mice were independently confirmed to be pathogen-free. They were also verified germ-free within the breeding isolators and during experiments (apart from the transient colonization and the colonized experiment shown in Figures S5B and  S5C ) by culture-dependent and -independent methods. All mouse experiments were performed in accordance with Swiss Federal and Cantonal regulations.
Microbe strains
Escherichia coli HA107 was constructed as an auxotrophic E. coli strain lacking synthetic capabilities of two amino acids, meso-DAP and D-alanine (Hapfelmeier et al., 2010) . It grows equivalent to wild-type E. coli via supplementing with 100 mg/mL meso-DAP and 400 mg/mL D-alanine in vitro, and only transiently colonizes germ-free mice due to its auxotroph (Hapfelmeier et al., 2010) .
METHOD DETAILS
Preconditioning the intestinal mucosa through transient bacterial colonization in germ-free mice E. coli HA107 bacterial overnight cultures were centrifuged at 3480g for 10 min at 4 C. After washing twice with sterile PBS, the required dose of bacteria was resuspended in PBS (10 10 CFU per 500 ml). The bacterial solution was gavaged directly into the mouse stomach on alternate days four times. One week after the last HA107 gavage, the feces from the mice were routinely verified by culture-dependent and -independent methods to be germ-free. Control germ-free mice were similarly treated in parallel throughout, although gavaged with an equivalent volume of sterile PBS. Preconditioned mice were studied further 14 days after the last conditioning dose.
Preparation of 13 C-labeled bacteria To prepare 13 C-labeled HA107, sterile 13 C-labeled bacterial extracts from E. coli MG1655 were used as source of 13 C-labeled amino acids and vitamins. For this, E. coli MG1655 was initially cultured in M9 medium using 13 C-D-glucose (Cambridge Isotope Laboratories) as sole carbon source. After three sequential subcultures, fully 13 C-labeled MG1655 bacterial extracts were obtained and sterilized by filtration (0.22 mm). E. coli HA107 was then cultured in M9 medium containing 13 C-D-glucose and 13 C-labeled bacterial extracts from E. coli MG1655. After three sequential cultures, the HA107 bacterial culture was centrifuged at 3480 g for 10 min at 4 C. After washing twice with sterile PBS, the required dose of HA107 bacteria was suspended in PBS (10 10 CFU per 500 ml). We verified that this protocol achieved essentially complete (> 90%) 13 C-labeling of the carbon chains of all bacterial molecules across all compound classes ( Figures S1D and S1E ).
Mass spectrometry
Samples were snap-frozen in liquid nitrogen. To prepare fluid samples for mass spectrometry, weighed fluid samples (50 mg) were precipitated with final 80% methanol for 1 hour at À20 C. After centrifugation at 20,000 g for 10 min at room temperature, the supernatant was transferred to Q-TOF plates. To prepare tissue samples for mass spectrometry, metabolites from weighed tissue samples (50 mg) were extracted with 20 times weight of Millipore water (80 C) followed by homogenization at 25 Hz for 2 min in a tissue homogenizer (Retsch MM 400) with a clean steel ball (Berani). After centrifugation at 20,000 g for 10 min at room temperature, supernatants were transferred to Q-TOF plates.
Quantification of relative metabolites concentrations was carried out with an Agilent 6550 Q-TOF mass spectrometer (Agilent Technologies Inc., Santa Clara, CA) by non-targeted flow injection analysis as described previously (Fuhrer et al., 2011) . Profile spectra with high mass accuracy were recorded from 50 to 1000 m/z in negative ionization mode. The common mass axis after sample alignment was recalibrated using known frequently occurring metabolite ions. Ions were finally annotated based on accurate mass comparison using 1 mDa mass tolerance against 9261 unique metabolites present in a pooled list of compounds derived from the Human Metabolome Database (Wishart et al., 2013) , E. coli genome scale-model (Orth et al., 2011) and the E. coli Metabolome Database (Sajed et al., 2016) . All potentially possible 13 C isotopes were annotated taking into acount the respective sum mass formula.
Determining the extent of 13 C-labeling in E. coli HA107 used for stable isotope tracing The free intracellular metabolites were extracted from the cell pellet with Millipore water at 80 C and analyzed by non-targeted flow injection analysis as described above. Proteinogenic amino acids were obtained from the extracted pellet after hydrolysis with 6 M HCl and subsequently derivatized with N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide as described previously (Nanchen et al., 2007) . The 13 C-labeling patterns were then determined on a 6890N Network GC system with a 5975 inert XL mass selective detector (Agilent Technologies Inc., Santa Clara, CA). Fractional label for both intracellular metabolites and proteinogenic amino acids was then estimated from the relative abundances of m 0 and m max ion counts as m max / (m 0 + m max ). C-HA107 gavaged samples were taken. Where shown, the Metamapp program was used to evaluate the Tanimoto chemical similarity index on compounds selectively present in one condition applying Cytoscape software for network visualization. Mann Whitney U test was performed using wilcox.test function in R (* = p < 0.05, ** = p < 0.01, *** = p < 0.001).
Metabolomics data analysis
Preparation of 14 C-labeled bacteria M9 medium supplemented with 100 mg/mL meso-DAP, 400 mg/mL D-alanine, 10 mg/mL lysine, 10 mg/mL threonine, 10 mg/mL methionine, 10 mg/mL proline, 4 mg/mL thiamine, 2 mM L-arabinose, and 5 mM succinate was inoculated with 1/100 th amount of E. coli HA107 (or JM83) overnight culture grown in LB medium. The culture was incubated with shaking at 180 rpm at 37 C. When the culture reached OD 600 0.28 ± 0.05, 2-[1-14 C]-deoxy-D-glucose (Perkin Elmer) was added. The bacterial culture was further incubated for 12-14 hours at 37 C. After harvesting the bacterial culture, the bacterial pellet was washed twice with PBS to remove unincorporated 14 C-radioactive materials and resuspended prior to gavage.
Cecal injection
For cecal injection mice were anaesthetized with isoflurane by inhalation (3.0 to 4.0% v/v isoflurane from a vaporizer with O 2 flow at 1-2 L/min). An incision ($1 cm) was made with curved scissors at left side of lower abdomen, and the cecum was located.
14 C-labeled HA107 was injected into the middle of cecum and mixed thoroughly with the contents. The abdominal incision was closed with AUTOCLIP Wound Clip System (BD). Temgesic (0.05-0.1 mg/g body weight) was injected subcutaneously for analgesia.
Liquid scintillation counting
Weighed samples were incubated with 1 mL of NCS Tissue Solubilizer (GE Healthcare) at 56 C until completely dissolved. The pH was neutralized with 200 ml of 100% acetic acid. Ultima Gold liquid scintillation cocktail (18 ml, PerkinElmer) was added to each sample. The 14 C-radioactivity in each sample was measured in a TRI-CARB 2300TR Liquid Scintillation Analyzer (Packard). Scintillation background for each fluid or tissue type was subtracted using matched samples from control germ-free mice that had not received 14 C-labeled bacteria.
RNA isolation
Tissue samples were snap-frozen in TRIzol reagent (Invitrogen) using liquid nitrogen. Thawed tissues in TRIzol reagent were immediately homogenized at 25 Hz for 2 min in a tissue homogenizer (Retsch MM 400) with sterile steel balls (Berani). Total RNA was isolated following the standard protocol from Invitrogen. The total RNA was further purified with RNeasy MinElute kit (QIAGEN). RNA quality was assessed on a Bioanalyzer 2100 (Agilent). Ribosomal RNA was removed with Ribominus Transcriptome Isolation Kit (Invitrogen). RNA libraries were prepared with TruSeq RNA sample preparation v2 kit (TruSeq Stranded mRNA Sample Preparation, Illumina). RNA sequencing was performed with Illumina HiSeq 2500 using the 150bp paired-end mode. Read quality control was with FastQC. Each read was mapped onto the mouse genome using TopHat2. Counts per gene were assessed using HTSeq-count software. Differential gene expression analysis was performed using DESeq2. Adjusted Log 2 fold-change and adjusted p-values (corrected for multiple testing) were used to determine significant differences in gene expression. Functional protein association networks of genes of adjusted p-value of < 0.05 were analyzed using the STRING database (version 10) taking network confidence scores R 0.4.
Live intestinal endomicroscopy
Mice investigated with endomicroscopy were anaesthetized with isoflurane inhalation as described for cecal injection on a heating pad at 37 C. The abdomen of the anaesthetized mouse was opened and a Cellvizio confocal miniprobe (Mauna Kea) was inserted into the intestinal ileal lumen. Fluorescein isothiocyanate (FITC)-dextran (0.5 mg, 70 kDa, Sigma) in PBS was injected intravenously to provide real-time vascular contrast. The fluorescence of FITC in the intestinal vasculature was recorded with Cellvizio software (Mauna Kea). Metrics of the endothelial and epithelial layers were evaluated with ImageJ software (NIH).
Enzyme-linked immunosorbent assay (ELISA)
The gastrointestinal tracts from HA107 conditioned germ-free C57BL/6 mice were separated according to section (duodenum, jejunum, cecum and colon). Isolated luminal contents from each section were weighed. IgA concentration was measured with ELISA using goat anti-mouse IgA (Bio-Rad Antibodies) coating antibody. The detection antibody was HRP-conjugated anti-mouse IgA (Sigma). Standards were myeloma-derived purified IgA (Hycult). The IgA concentration in the contents of each germ-free intestinal segment was plotted.
Bacterial immunofluorescent staining E. coli HA107 was cultured without shaking at 37 C for overnight. The bacteria were then washed in PBS and resuspended at 10 7 per ml. Portions (50 ml) of the bacterial suspension were dropped onto glass slides and the bacterial drop was encircled using a wax pen. Bacteria were allowed to sediment onto the glass slides and to dry. Transiently flamed bacteria on glass slides were stained with intestinal wash prepared from small intestine of HA107 conditioned germ-free C57BL/6 mice. The IgA antibodies bound to bacteria were visualized with FITC-conjugated anti-mouse IgA (BD Bioscience). DAPI (4', 6-diamidino-2-phenylindole) was used to counterstain the bacterial DNA. Immunofluorescent pictures were taken using Flash Slide Scanner (PerkinElmer) with 40 magnifications.
Bacterial motility assay E. coli expressing GFP constitutively were resuspended at 10 8 CFU/mL with PBS-based intestinal wash from either HA107 conditioned C57BL/6 or Igh-J À/À mice. Bacteria were then loaded to microfluid chips. Serial pictures were taken every second over 5 min by Zeiss LSM 700 confocol microscope. The images were transformed into time-lapse videos with Volocity software (PerkinElmer).
Bacterial intestinal transit time
Germ-free C57BL/6 and Igh-J À/À mice were conditioned with HA107 as described previously. For small intestinal transit, 10 7 CFU of HA107 were introduced directly into the stomachs of mice. Two hours after the intragastric gavage, small intestines were collected and separated into 10 sections of identical length from duodenum to ileum. All luminal contents in each section were plated on LB agar plates with the auxotrophic supplements and results were evaluated for each segment. To measure whole intestinal transit time, 10 10 CFU of HA107 were introduced to the stomachs of mice. Feces were sequentially collected and cultured as described previously.
Metabolite-specific ELISA Metabolite-specific ELISA was performed to address the binding of intestinal IgA to purified identified metabolites including pentadecanoic acid (Sigma); 5-methoxytryptamine (Sigma); N-acetylaspartylglutamic acid (Sigma); scopolamine hydrochloride (Sigma); D-maltose (VWR) and heptadecanoic acid (Sigma). E.coli LPS (Sigma) and DNA from E. coli were used as controls. ELISA plates (Milian) were coated with 50ml/well of 10mg/mL antigen overnight (ON) using coating buffer (0.1M NaHCO 3 ) except pentadecanoic acid and heptadecanoic acid coated using 100% ethanol. After blocking (PBS with 2% BSA, RT, 2h), serial diluted intestinal washes containing IgA were added to the plates and incubated for 2 hours. To reveal the IgA binding affinity to metabolites, HRP conjugated anti-IgA antibody (1:100, Sigma) was added to each well and incubated for 45 min. Plates were then washed (4X, PBS containing 0.5% Tween-20) and developing reagent (100 mL per well, 1mg ABTS plus 5ml H 2 O 2 /10ml 0.1 M NaH 2 PO 4 ) was added. Samples then were read at OD 415 using an ELISA plate reader.
Cytokine release assays
Mice used in cytokine release assays were preconditioned with HA107 as described in Method Preconditioning. Peritoneal cells were collected by gentle flushing of the peritoneal cavity with RPMI 1640 medium; splenocytes, mesenteric lymph node cells (MLN cells) and bone marrow cells harvested from mouse femur were isolated using a 100mm cell strainer. After red blood cell lysis, 2 3 10 6 cells/mL were prepared in complete medium (RPMI 1640 with 10% FBS, 50 mM b-mercaptoethanol, 100 U/mL penicillin/ streptomycin and 2mM HEPES). A 100ml suspension was seeded in each well of 96-well cell culture plates (Thermo Fisher). The natural cytokine release from cells was determined after incubating at 37 C supplemented with 5% CO 2 for 2 hours. For in vitro stimulation with metabolites/bacteria-derived components, 250mg/mL of each compound as listed was added to the culture and incubation was carried out for 6 hours. The culture supernatants were collected for further analysis.
Intraperitoneal challenge with pentadecanoic acid or 5-methoxytryptamine Mice were preconditioned with HA107 or left untreated. Two weeks after the last oral bacterial priming, mice were intraperitoneally injected with 1mg/kg body weight pentadecanoic acid or 5-methoxytryptamine. 6 hours after injection, cells were isolated from indicated lymphoid organs and cultured for 2 hours. The supernatants were collected for further analysis.
Cytokine quantification
Cytokine measurements were performed using the Meso Scale Discovery (MSD) system. Samples were initially diluted 1:1 with commercial MSD diluent buffer and added into Meso Scale 19-plex plates. Serial titrations of cytokine standards were also added to the plates. After overnight incubation, plates were washed (3X, PBS with 0.5% Tween-20) and a panel of commercial 19 secondary antibodies was added to plates and incubated for 2 hours following the manufacturer's protocol and instructions. Plates were then washed (3X, PBS containing 0.5% Tween-20), and 150ml substrate buffer was added into each well. Plates were then read on Meso Scale plate reader.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the definitions and exact values of n (e.g., number of experiments, number of mice, etc) and distributions are reported in the Figure Legends . Mann-Whitney U test was used for all metabolomic comparisons and unpaired student-t test was performed in intestinal transit tests and microbial culture related tests. Statistical analysis was performed in GraphPad Prism and R software. In all figures: * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
DATA AND SOFTWARE AVAILABILITY
The RNA sequencing data files have been deposited in the NCBI Gene Expression Omnibus under accession number GEO:GSE102543. String analysis (https://string-db.org/) has been used to elucidate the RNA sequencing data. All original metabolomic data are available at http://www.mucosalimmunology.ch/de/The-lab-University-of-Bern/Supplementary-resources-ofPublications. 
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A l a n i n e G l y c i n e V a l i n e L e u c i n e I s o l e u c i n e P r o l i n e M e t h i o n i n e S e r i n e T h r e o n i n e P h e n y l a l a n i n e Figure S1 . Stable isotope tracing design for concurrent measurement of penetration of microbial metabolites and the host response (related to Figure 1 ).
(A)
i) The schematic representation shows the experimental design of germ-free control mice challenged with 13 C or 12 C non-replicating bacteria and subsequent sequential sampling.
ii) The extended schematic representation shows the experimental design using mice that were preconditioned with transitory bacterial colonization in order to mature immune and non-immune consolidated intestinal barrier functions and comparison with non-conditioned controls. Two weeks later they received 13 C or 12 C non-replicating bacterial challenge or control PBS gavage with subsequent sequential sampling to determine 13 C bacterial metabolite penetration into the host and the 12 C host response. Germ-free C57BL/6 mice were gavaged with 13 C-labelled HA107 or PBS as control (n = 3 -4 mice per group). Fluid samples were collected 2 or 18 hours later and analyzed with Q-TOF mass spectrometry. Figure S3 . Penetration of bacterial products into systemic sites after treatment with E.coli HA107 or its replication-competent parent strain and determination of sensitivity of colonisation without significant gastric microbial killing (related to Figure 3 ).
(A-C) 14 C-labelled E. coli HA107 (after growth on 14 C-glucose; closed circles) was administered directly into the stomach or mixed directly with the cecal contents (open circles) of germ-free C57BL/6 mice. For comparison, 14 C-labelled E. coli JM83 (the replication competent parent strain of HA107; red triangles) was administered into the stomach of a separate group of mice. 14 C-radioactivity in (A) mesenteric lymph nodes, (B) liver and (C) kidney were monitored at 2, 8, and 18 hours after oral gavage or cecal administration. Background radioactivity from the respective solid or liquid samples of control germ-free mice was subtracted and results shown as a percentage of gavage equivalent of the bacterial cocktail used for the oral gavage or cecal administration. The results were pooled from two independent experiments. (D) Serial dilutions (10 -1 , 10 0 , 10 1 , and ≥ 10 2 CFU) of E. coli JM83 (HA107 parent strain) were orally administrated to germ-free C57BL/6 mice. After 18 hours of colonisation, cecal contents was cultured on LB plates, and the total CFU/gram contents were plotted. Each point represents one mouse. (E) Live 14 C-labelled HA107, live 14 C-labelled JM83 and sonication-generated 14 C-labelled E. coli HA107 lysis were gavaged to germ-free C57BL/6 mice. Serum samples were collected from mice at 2, 8 and 18 hours post gavage. Radioactivity of serum samples were analyzed as in Figure 3A . (E) The survival of HA107 was determined over time in small intestinal blind-loops. Surgically created small bowl loops of HA107 conditioned or untreated germ-free C57BL/6 or Igh-J -/-mice were injected with 500 µl of 10 10 HA107. At indicated time points, samples were collected and plated to calculate the bacterial survival. (F) Antigen specific ELISA was used to determine the direct binding of IgA to purified flagellin. Intestinal fluid prepared from either HA107 conditioned C57BL/6 or conditioned Igh-J -/-mice was used as primary antibody. Data shown are mean±SD, n = 4. (G and H) E. coli was incubated with freshly prepared intestinal washes from either HA107-conditioned C57BL/6 or Igh-J -/-mice. The motility of GFP labelled bacteria were tracked by Zeiss LSM 700 confocal microscopy (supplementary videos 1 and 2). Bacterial velocities were quantified using Volocity software to semi-automatedly track bacterial motility (G). Bacteria were seeded on semi-solid motility agar after incubation with intestinal fluid as in G, and diameters of bacterial rings were measured after incubation at 37˚C for overnight (H). 
